China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prospective, Single-Arm, Phase II Clinical Study of Ivonescimab Combined with TROP2 ADC ... Read More
China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy of Different Treatment Regimens for IgA Nephropathy and Their Ef... Read More
China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of Baduanjin Exercise on Patients with Type 2 Diabetes Mellitus: An Analysis Bas... Read More
China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Analysis of factors influencing infliximab efficacy for Crohn's disease and construction... Read More
China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Practical Study on Nonpharmacological Interventions for Patients With MetabolicAssocia... Read More
China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Randomized Controlled Study on the Use of Kangfuxin Solution for Wound Healing and Compl... Read More
China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on Multi-Dimensional Data Integration Application of Pulmonary Nodules'. The fo... Read More
China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effects of Ciprofol on Intraoperative Hemodynamics and Postoperative Recovery Quality in... Read More
China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prediction of Delivery Timing for Patients with Intrahepatic Cholestasis of Pregnancy Ba... Read More
China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Association Between Free Triiodothyronine/Free Thyroxine (FT3/FT4) and Glycemic Manageme... Read More